Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jim Stankovich

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 2013
Vitamin D status: multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradientRobyn M Lucas, Anne-Louise Ponsonby, Keith Dear, et al.
Human Genetics|April 22, 2010
Genome-wide linkage scan and association study of PARL to the expression of LHON families in ThailandNopasak Phasukkijwatana, Bussaraporn Kunhapan, Jim Stankovich, et al.
International Journal of MS Care|June 28, 2021
Patient Preferences for Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic DisordersLouise Rath, Maria Pia Campagna, Jim Stankovich, et al.
Human Genetics|January 13, 2006
On the utility of data from the International HapMap Project for Australian association studiesJim Stankovich, Charles J Cox, Rachel B Tan, et al.
European Journal of Medical Genetics|June 13, 2017
Familial epilepsy with anterior polymicrogyria as a presentation of COL18A1 mutationsMark A Corbett, Samantha J Turner, Alison Gardner, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2024
The immune cell transcriptome is modulated by vitamin D<sub>3</sub> supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trialWei Zhen Yeh, Melissa Gresle, Rodney Lea, et al.
Neurology|February 2, 2024
Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying TherapiesFrancesca Bridge, Julia Brotherton, Jim Stankovich, et al.
Therapeutic Advances in Neurological Disorders|May 5, 2021
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patientsChristopher M Dwyer, Vilija G Jokubaitis, Jim Stankovich, et al.
Novartis Foundation Symposium|July 8, 2005
Multiple sclerosis: a haplotype association studySimon J Foote, Justin P Rubio, Melanie Bahlo, et al.
Immunology and Cell Biology|June 14, 2024
Transcriptional network analysis of peripheral blood leukocyte subsets in multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated gene network in myeloid cellsMargaret A Jordan, Melissa M Gresle, Adrian T Gemiarto, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
The Journal of Steroid Biochemistry and Molecular Biology|February 12, 2013
Vitamin D status: multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradientRobyn M Lucas, Anne-Louise Ponsonby, Keith Dear, et al.
Human Genetics|April 22, 2010
Genome-wide linkage scan and association study of PARL to the expression of LHON families in ThailandNopasak Phasukkijwatana, Bussaraporn Kunhapan, Jim Stankovich, et al.
International Journal of MS Care|June 28, 2021
Patient Preferences for Time and Location of Infusible Therapies in Multiple Sclerosis and Neuroimmunologic DisordersLouise Rath, Maria Pia Campagna, Jim Stankovich, et al.
Human Genetics|January 13, 2006
On the utility of data from the International HapMap Project for Australian association studiesJim Stankovich, Charles J Cox, Rachel B Tan, et al.
European Journal of Medical Genetics|June 13, 2017
Familial epilepsy with anterior polymicrogyria as a presentation of COL18A1 mutationsMark A Corbett, Samantha J Turner, Alison Gardner, et al.
Clinical Immunology (Orlando, Fla.)|March 13, 2024
The immune cell transcriptome is modulated by vitamin D<sub>3</sub> supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trialWei Zhen Yeh, Melissa Gresle, Rodney Lea, et al.
Neurology|February 2, 2024
Risk of Cervical Abnormalities for Women With Multiple Sclerosis Treated With Moderate-Efficacy and High-Efficacy Disease-Modifying TherapiesFrancesca Bridge, Julia Brotherton, Jim Stankovich, et al.
Therapeutic Advances in Neurological Disorders|May 5, 2021
High rates of JCV seroconversion in a large international cohort of natalizumab-treated patientsChristopher M Dwyer, Vilija G Jokubaitis, Jim Stankovich, et al.
Novartis Foundation Symposium|July 8, 2005
Multiple sclerosis: a haplotype association studySimon J Foote, Justin P Rubio, Melanie Bahlo, et al.
Immunology and Cell Biology|June 14, 2024
Transcriptional network analysis of peripheral blood leukocyte subsets in multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated gene network in myeloid cellsMargaret A Jordan, Melissa M Gresle, Adrian T Gemiarto, et al.
Pageof 9